Niamh Quann

Niamh is a Senior Clinical Research Manager in the Department of Cardiovascular Sciences (Renal). She has worked at the University of Leicester since 2017 and has 10+ years' experience in clinical trials, with a strong background in trial management, delivery, and governance. In her current role, Niamh oversees the operational delivery and strategic management of renal and dialysis clinical trials. As Trial Governance Lead for the Leicester Partnership for Kidney Health Research, she supports a diverse and growing portfolio, ensuring high standards of compliance and regulatory oversight.

Alongside her core responsibilities, Niamh has been an active member of the East Midlands - Leicester South Research Ethics Committee (REC) since 2020 and serves as a REC Mentor with the Health Research Authority (HRA), providing support and guidance to newly appointed REC members as they learn about the research ethics review process. Niamh also regularly contributes to academic publishing as a peer reviewer for BMJ Open, BMJ Global Health, and Trials.

Cluley V, Eborall H, Hull K, Quann N, Burton JO. Progressing the understanding of chronic illness and its treatment: A post-human, ethological understanding of haemodialysis. Health. 2023;28(5):716–35. doi:10.1177/13634593231200126.

Hull KL, Bramham K, Brookes CL, et al. The NightLife study—the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial. Trials. 2023;24:522. doi:10.1186/s13063-023-07565-w.

Cluley V, Burton JO, Quann N, Hull K, Eborall H. Biographical dialectics: The ongoing and creative problem solving required to negotiate the biographical disruption of chronic illness. Soc Sci Med. 2023;325:115900. doi:10.1016/j.socscimed.2023.115900.

Quann N, Burns S, Hull KL, et al. Reducing the carbon footprint of research: experience from the NightLife study. BMJ Open. 2023;13:e070200. doi:10.1136/bmjopen-2022-070200.

Hull KL, Quann N, Fotheringham J, Conefrey C, Burton J, NightLife Study Investigators. Using internal pilot data to create a dynamic recruitment strategy: experience from the NightLife trial: SA-OR57. J Am Soc Nephrol. 2023;34(11S):76–7. doi:10.1681/ASN.20233411S176d.

Yousuf AJ, Mohammed S, Carr L, Ramsheh MY, Micieli C, Mistry V, et al. Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial. Lancet Respir Med. doi:10.1016/S2213-2600(21)00556-7.

Hull KL, Quann N, Glover S, et al. Evaluating the clinical experience of a regional in-center nocturnal hemodialysis program: The patient and staff perspective. Hemodialysis International. 2021; 25: 447–456. https://doi.org/10.1111/hdi.12953 Mitchell, E.J., Ahmed, K., Breeman, S. et al. It is unprecedented: trial management during the COVID-19 pandemic and beyond. Trials 21, 784 (2020). https://doi.org/10.1186/s13063-020-04711-6

Narendran P, Greenfield S, Troughton J, Doherty Y, Quann N, Thompson C, et al. Development of a group structured education programme to support safe exercise in people with Type 1 diabetes: the EXTOD education programme. Diabet Med. 2020;37:945–52. doi:10.1111/dme.14064.

Narendran P, Quann N, Nagi D, Gallen I, Gorton J, Daly H, et al. Rationale and methods for the Exercise for Type 1 Diabetes Education program: a pilot randomized controlled trial of an education program to support adults with type 1 diabetes mellitus (T1DM) to undertake exercise. BMJ Open Diabetes Res Care. 2019;7:e000693.

Soady I, MacCabe K, Bunch G, Hyde A, Rawlings C, Round M, et al. Opportunities to participate in clinical trials: awareness among liver patients. Gastrointest Nurs. 2018;16(1):30–6. doi:10.12968/gasn.2018.16.1.30.

Master's Degree, Public Health - University College Cork, Ireland (2012)

BSc (Hons), Public Health and Health Promotion - University College Cork, Ireland (2011)